 Codexis Inc NASDAQ: CDXS has amended and extended its agreement with Merck Co Inc NYSE: MRK to license and supply a proprietary enzyme used to manufacture sitagliptin. Sitagliptin is an active pharmaceutical ingredient API in Mercks two anti-diabetic medications, Januvia and Janumet. 